TürkiyeResearch and clinical trials
274 adult aplastic anemia patients from 16 centers studied in Türkiye: 5-year survival rate 72.6%
A study published in a journal and reviewed by independent scientists. Even so, a single study is not conclusive; it needs to be replicated.
In Türkiye, the records of 274 adult patients at 16 centers were reviewed. Diagnoses had been made between 2011 and 2021. In 72% of patients, the disease was severe. An average of 119 days passed from diagnosis to first treatment. After five years, 72.6% of patients were alive. Stem cell transplant and other first-line treatments led to improvement in most patients.
What does it mean for patients and families?
This provides a local picture for adult patients in Türkiye. It is a retrospective study. Reaching a hematologist quickly is important to start treatment early.
Source
Scientific paper: Assessment of characteristics and treatment patterns of adult patients with acquired aplastic anemia in Turkiye (PLANE-TR). Annals of Hematology, 2026. DOI: 10.1007/s00277-026-06871-y · PubMed 41718772
The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).
This page is translated from the Turkish original.
Related disease: Acquired aplastic anemia
This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.